ProfileGDS4095 / 230464_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 27% 39% 38% 35% 34% 37% 42% 39% 46% 41% 40% 43% 41% 42% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep12.2482627
GSM709769LY2 SRC1-siRNA tamoxifen treated rep32.7035239
GSM709765LY2 SRC1-siRNA untreated rep32.6723138
GSM709771LY2 SRC1-siRNA untreated rep12.5394335
GSM709772LY2 SRC1-siRNA untreated rep22.4964834
GSM709775LY2 SRC1-siRNA untreated rep42.6328137
GSM709764LY2 control-siRNA tamoxifen treated rep22.9091242
GSM709766LY2 control-siRNA tamoxifen treated rep32.7184339
GSM709768LY2 control-siRNA tamoxifen treated rep13.1101746
GSM709777LY2 control-siRNA tamoxifen treated rep42.8304941
GSM709770LY2 control-siRNA untreated rep32.7459240
GSM709773LY2 control-siRNA untreated rep12.9108243
GSM709774LY2 control-siRNA untreated rep22.8365341
GSM709776LY2 control-siRNA untreated rep42.8844842